ReviewDie Ophthalmologie2026
[Scleral buckling for rhegmatogenous retinal detachment-The value of buckle procedures in modern retinal surgery].
Review in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRhegmatogenous retinal detachment (RRD) is a potentially acute vision-threatening condition. While scleral buckling (SB) was considered the standard treatment for decades, it has increasingly been replaced by pars plana vitrectomy (ppV).
objectiveThis study aims to re-evaluate the role of SB within the current therapeutic context by comparing the clinical outcomes of SB versus primary ppV for RRD, based on data published from 2005-2025. MATERIAL AND
methodsA systematic literature search across five databases identified 24 studies (2005-2025) comparing SB and ppV in primary RRD. Exclusion criteria included patient age under 18 years and proliferative vitreoretinopathy (PVR) greater than grade B. Outcomes were analyzed in terms of preoperative and postoperative corrected distance visual acuity (CDVA) and single surgery anatomical success (SSAS).
resultsAcross all included studies the mean preoperative CDVA was 1.22 logMAR. Postoperatively, visual acuity improved to 0.49 logMAR with SB and to 0.5 logMAR with ppV. In phakic eyes, SB resulted in an average postoperative CDVA of 0.17 logMAR, whereas ppV achieved a mean of 0.23 logMAR in the same subgroup. The SSAS was reported to be up to 93.8% for SB and up to 96.3% for ppV.
conclusionScleral buckling remains an effective therapeutic option for selected patient populations, particularly those with a phakic lens status. Given its clinical relevance, SB should continue to be an integral part of surgical training programs.
Indexed as
Identifiers
41636816What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.